Complications of ERCP

R Talukdar - Best practice & research Clinical gastroenterology, 2016 - Elsevier
Even though considered safe, endoscopic retrograde cholangiopancreatography (ERCP) is
among the endoscopic procedures associated with the highest rate of complications. Post …

ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline

JM Dumonceau, C Kapral, L Aabakken… - …, 2020 - thieme-connect.com
Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or
indomethacin immediately before endoscopic retrograde cholangiopancreatography …

Post-endoscopic retrograde cholangiopancreatography pancreatitis

AM Thaker, JD Mosko, TM Berzin - Gastroenterology report, 2015 - academic.oup.com
Acute pancreatitis remains the most common complication of endoscopic retrograde
cholangiopancreatography (ERCP). It is reported to occur in 2–10% of unselected patient …

Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline–updated June 2014

JM Dumonceau, A Andriulli, BJ Elmunzer… - …, 2014 - thieme-connect.com
This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy
(ESGE). It addresses the prophylaxis of post-endoscopic retrograde …

The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement

NS Choksi, EL Fogel, GA Cote, J Romagnuolo… - Gastrointestinal …, 2015 - Elsevier
Background It is believed, based on limited observational data, that an unsuccessful attempt
to place a prophylactic pancreatic stent substantially increases the risk of post-ERCP …

Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review

NM Kubiliun, MA Adams, VS Akshintala… - Clinical …, 2015 - Elsevier
Background & Aims There is controversy over the efficacy of pharmacologic agents for
preventing pancreatitis after endoscopic retrograde cholangiopancreatography (PEP). We …

Systematic review with network meta‐analysis: pharmacological prophylaxis against post‐ERCP pancreatitis

VS Akshintala, SM Hutfless… - Alimentary …, 2013 - Wiley Online Library
Background The efficacy of many pharmacological agents for preventing post‐ERCP
pancreatitis (PEP) has been evaluated in randomised controlled trials (RCT s), but it is …

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

S Inamdar, D Han, M Passi, DV Sejpal… - Gastrointestinal …, 2017 - Elsevier
Background and Aims Rectal indomethacin is a popular chemopreventive agent to help
prevent post-ERCP pancreatitis (PEP). Previous meta-analyses have shown an overall …

Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and …

SFV di Prampero, G Faleschini, N Panic… - European Journal of …, 2016 - journals.lww.com
Methods PubMed, Embase, Science Citation Index, Ovid, and the Cochrane Controlled
Trials Register were searched by two independent reviewers to identify full-length …

Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials

J Ding, X Jin, Y Pan, S Liu, Y Li - PloS one, 2013 - journals.plos.org
Background Acute pancreatitis is the most common complication of diagnostic and
therapeutic endoscopic retrograde cholangiopancreatography (ERCP). Several clinical trials …